Can a flash of UV light stop surgical infections?
NCT ID NCT07600463
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether shining UVC light on the surgical area during brain surgery can prevent wound infections. 75 adults with normal pressure hydrocephalus who need a shunt will be randomly assigned to receive real UVC light or a sham device. The researchers will check for germs in the wound and monitor for any harm to the skin.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- UVC light (270nm) from a device
- What this could lead to
- If it works, this could offer a simple way to reduce surgical infections without drugs.
- What could go wrong
- This is a very small, early study with only 75 patients. The UVC light might not reduce infections and could harm healthy tissue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 75 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 75 patients with idiopathic normal pressure hydrocephalus (iNPH) arriving for CSF shunt procedure * written informed consent Exclusion Criteria: * immunosupressive medication * pregnancy * medication sensitizing for light exposure (e.g. doxycycline)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hydrocephalus are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kuopio University Hospital
Kuopio, Puijonlaaksontie 2, 70210, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radiation-Free brain imaging for kids? ultrasound may offer a safer path
- Can a Brain-Stiffness scan spot a treatable form of dementia?
- Wearable device could monitor brain shunt function from home
- Keyhole brain surgery could spare children from shunt complications
- Sticker on the skin could replace scans for shunt checks
- New MRI method could spot reversible dementia more accurately